Petra Clowes

Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial

Grant Theron, Lynn S. Zijenah, Duncan Chanda et al. · The Lancet · 2013 · 437 citations

Point-of-care Xpert Mtb/rif, Pulmonary Tuberculosis, Primary Care +12

Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial

Jonny Peter, Lynn S. Zijenah, Duncan Chanda et al. · The Lancet · 2016 · 262 citations

Pulmonary Tuberculosis, Treatment And Prevention, Medicine +12

Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study

Matthew Bates, Justin O’Grady, Markus Maeurer et al. · The Lancet Infectious Diseases · 2012 · 155 citations

Pulmonary Tuberculosis, Global Health, Pediatrics +9

Increased and Expedited Case Detection by Xpert MTB/RIF Assay in Childhood Tuberculosis: A Prospective Cohort Study

Andrea Rachow, Petra Clowes, Elmar Saathoff et al. · Clinical Infectious Diseases · 2012 · 142 citations · Full text

Assessment of the novel T-cell activation marker–tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study

Damien Portevin, Félicien Moukambi, Petra Clowes et al. · The Lancet Infectious Diseases · 2014 · 136 citations

Pulmonary Tuberculosis, Allergy, Immunodeficiencies +8